Twist Bioscience (NASDAQ: TWST) revenue
Twist Bioscience reported revenue of $376.6m for fiscal 2025, 20.3% more than in fiscal 2024 ($313.0m). Since fiscal 2018 its revenue has grown by 1,381.0%, an average growth of 47.0% a year.
Twist Bioscience has grown its revenue for 7 years in a row, and fiscal 2025 is the highest of its 8 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $376.6m | +20.3% | −$136.3m | −36.2% |
| 2024 | $313.0m | +27.7% | −$220.8m | −70.6% |
| 2023 | $245.1m | +20.4% | −$217.2m | −88.6% |
| 2022 | $203.6m | +53.8% | −$234.8m | −115.3% |
| 2021 | $132.3m | +46.9% | −$152.7m | −115.4% |
| 2020 | $90.1m | +65.7% | −$140.1m | −155.5% |
| 2019 | $54.4m | +113.9% | −$108.9m | −200.1% |
| 2018 | $25.4m | — | −$70.6m | −277.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Twist Bioscience revenue compared with its sector
By revenue for its latest fiscal year, Twist Bioscience ranks 209th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Twist Bioscience, 20.3%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 207th | Sonida Senior Living | $381.1m | 25.2% |
| 208th | CareDx | $379.8m | 13.8% |
| 209th | Twist Bioscience | $376.6m | 20.3% |
| 210th | Arcutis Biotherapeutics | $376.1m | 91.3% |
| 211th | MannKind | $349.0m | 22.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Twist Bioscience
- How much revenue did Twist Bioscience make in fiscal 2025?
- Twist Bioscience reported revenue of $376.6m for fiscal 2025, compared with $313.0m in fiscal 2024.
- How much has the revenue of Twist Bioscience grown?
- Between fiscal 2018 and fiscal 2025 it went from $25.4m to $376.6m: 1,381.0% more, an average growth of 47.0% a year.
- What was the best year for revenue at Twist Bioscience?
- Of its last 8 fiscal years, fiscal 2025, with $376.6m.
- Where does Twist Bioscience rank in its sector by revenue?
- It ranks 209th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Twist Bioscience come from?
- From the annual report (Form 10-K) that Twist Bioscience files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Twist Bioscience files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Twist Bioscience: the Twist Bioscience page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.